Insiders 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Real-time Estimate Cboe BZX Other stock markets 01:33:10 2024-05-02 pm EDT			5-day change	1st Jan Change
26.34 ^USD	+3.72%		+12.20%	+30.31%

Apr. 15	Barclays Starts 4D Molecular Therapeutics With Overweight Rating, $45 Price Target	MT
Apr. 15	RBC Raises Price Target on 4D Molecular Therapeutics to $40 From $35, Keeps Outperform Rating, Speculative Risk Qualifier	MT

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

4D Molecular Therapeutics Insider Sold Shares Worth $259,102, According to a Recent SEC Filing	Apr. 04	MT
4d Molecular Therapeutics Insider Sold Shares Worth $737,788, According to a Recent SEC Filing	Feb. 08	MT
4D Molecular Therapeutics, Inc. Announces Management Changes	Jan. 04	CI
4D Molecular Names New Chief Financial and Business Officer	23-09-12	MT
4D Molecular Therapeutics, Inc. Appoints Uneek Mehra as Chief Business Officer	23-09-12	CI
Insider Sell: 4D Molecular Therapeutics	22-12-19	MT
Insider Sell: 4d Molecular Therapeutics	22-12-05	MT
4D Molecular Therapeutics Names Fred Kamal President, Chief Operating Officer	22-09-27	MT
4D Molecular Therapeutics, Inc. Appoints Noriyuki Kasahara, MD, PhD to the Board of Directors and Promotes Fred Kamal, PhD to President and Chief Operating Officer	22-09-27	CI
4D Molecular Therapeutics, Inc. Announces Resignation of David Schaffer from Its Board of Directors and His Roles on the Nominating and Corporate Governance Committee and Science & Technology Committee	22-02-22	CI
Insider Sell: 4d Molecular Therapeutics	21-10-25	MT
Insider Sell: 4d Molecular Therapeutics	21-10-01	MT
Insider Sell: 4d Molecular Therapeutics	21-09-29	MT
4D Molecular Therapeutics, Inc. Appoints Nadine Greiner as Chief Human Resources Officer	21-08-12	CI
4D Molecular Therapeutics Appoints Carolyne Zimmermann as Chief Business Officer	21-06-07	CI
Mr. William Burkoth to Not Stand for Re-Election as Director of 4D Molecular Therapeutics, Inc	21-04-06	CI
4D Molecular Therapeutics, Inc. Announces Changes to Its Board	21-03-25	CI
4D Molecular Therapeutics, Inc Announces Executive Appointments	20-12-02	CI
4D Molecular Therapeutics, LLC Announces Board Appointments	20-11-18	CI
4D Molecular Therapeutics Appoints John F. Milligan as Executive Chairman of Board of Directors	20-09-08	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders 4D Molecular Therapeutics, Inc.

Equities

FDMT

US35104E1001

Insiders

Filters